About Endotronix
Endotronix is a Healthcare company based in East Peoria (United States) founded in 2007, and was acquired by Edwards Lifesciences in July 2024. Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. It operates in the Healthcare and Technology sectors. Endotronix has raised $154.77 million across 12 funding rounds from investors including SVB, Edwards Lifesciences and Life Sciences Partners. The company has 104 employees. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its legal entity is ENDOTRONIX, INC. Its competitors include Ekso Bionics, Edwards Lifesciences and CoachCare; 2 of its 3 listed competitors have raised funding.
Company details
Endotronix was founded in 2007 in East Peoria, United States, within the medical device sector focused on cardiology. Wireless and implantable pressure sensors are developed to measure cardiac function parameters. A care management solution is provided, enabling pulmonary artery pressure data to be captured via mobile devices and securely transmitted to clinical care teams for analysis and personalized patient oversight.
- Headquarters East Peoria, United States
- Employees 104
- Stage Acquired
- SectorsHealthcareTechnology
- Website endotronix.com
- Social LinkedIn X
- Acquired by Edwards Lifesciences (Jul 2024)
- Legal Name Endotronix, Inc.
- Total Equity Funding$154.77M (USD)
in 12 rounds
- Latest Funding Round$69.28M (USD), Series D
Oct 2019
- InvestorsSVB
& 11 more
- Employee Count104
- Acquired byEdwards Lifesciences
(Jul 2024)
Funding Insights of Endotronix
Endotronix has successfully raised a total of $154.77M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $69.28 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $154.77M
- Total Rounds 12
- Last Round Series D — $69.28M
- First Round $50,000
(Jan 2008)
- Investors Count 11
Latest 10 of 12 funding rounds of Endotronix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $69.28M | Series D | – | Life Sciences Partners | |
| Sep 2018 | $45M | Series D | – | Life Sciences Partners | |
| Feb 2018 | $37.1M | Series C | – | – | |
| Jan 2017 | $12M | Debt – Conventional | – | – | |
| Dec 2015 | $2.96M | Debt – Conventional | – | – | – |
| Feb 2015 | $2.2M | Debt – Conventional | – | – | – |
| Apr 2014 | $1.6M | Series A | – | – | – |
| Jun 2013 | $1.19M | Debt – Conventional | – | – | – |
| Aug 2012 | $1.8M | Debt – Conventional | – | – | – |
| Sep 2010 | $240,000 | Seed | – | – |
12 investors in total: 12 institutional.
Investors in Endotronix
Endotronix has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Edwards Lifesciences and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
A healthcare-focused investment firm supporting innovative company growth. | aperturevp.com | |||
Investment in emerging and growth-stage MedTech companies is facilitated. | bioventuresinvestors.com | Marlborough, United States | ||
Lumira Ventures is engaged in life sciences venture capital investment. | lumiraventures.com | Toronto, Canada | ||
Venture capital firm investing in early-stage healthcare companies | wanxianghealthcare.com | Elgin, United States | ||
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
Investments in lower mid-market companies are managed by Skydeck Capital. | skydeckllc.com | Chicago, United States | ||
Venture capital funding is provided to tech startups by JumpStart Ventures. | jumpstart.vc | Cleveland, United States | ||
Seroba Lifesciences is focused on life sciences venture capital investments. | seroba-lifesciences.com | Dublin, Ireland | ||
Standalone pediatric hospital services are provided in Peoria. | 1877 | osfhealthcare.org | Peoria, United States |
Investor details for Endotronix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Endotronix
38 people are tracked at Endotronix (9 in leadership, 5 in board & advisors, 24 in team); the tracked headcount is 104.
| Name | Role | Group |
|---|---|---|
Michael Nagy | Engineer & product development | Leadership |
Harry D. Rowland | CEO, Co-Founder & Board Member | Leadership |
Lisbert Avila-Yu | VP, Regulatory & Quality | Leadership |
Christian J. Gonzalez | Director Of Marketing And Product Management | Leadership |
Brent Horsley | Senior Director Sales Operations | Leadership |
Peter Branecky | Senior Medical Director | Leadership |
Kate Jacobson | Director, Post-market Quality | Leadership |
J. Michael Culen | Senior Vice President Of Sales & Commercial | Leadership |
Brett Quas | Vice President Of Software Engineering | Leadership |
Jennifer McMahon | Board Member | Board & advisors |
Gerry Brunk | Board Member | Board & advisors |
James J. Hummer | Board Member | Board & advisors |
Paul Laviolette | Chairman | Board & advisors |
Marc Goldberg | Board Member | Board & advisors |
Tracey Dill | Clinical Operations Manager | Team |
Scott Rich | Area Sales Manager | Team |
Jennifer Colnick | Area Sales Manager | Team |
Amanda Poland | Marketing Communications Manager | Team |
Ryan Goelz | Regional Manager- EAST | Team |
Annmarie Scully | Manager, Clinical Development | Team |
18 more people are available in the full profile.
Complete people profiles for Endotronix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Endotronix
4 dated milestones of Endotronix across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Endotronix is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Series D, of $69.3M.
- Exit Acquired by Edwards Lifesciences.
Competitors of Endotronix
Endotronix has 3 listed competitors in our database, 2 of them funded. They include Ekso Bionics, Edwards Lifesciences and CoachCare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eksobionics.com | 2005 | United States | $24.37M | 56 | Exoskeletons for medical rehabilitation and industrial productivity are provided. | |
| edwards.com | 1958 | Irvine, United States | 19,800 | Medical devices for structural heart disease are developed and provided. | ||
| coachcare.com | 2013 | New York, United States | $60.2M | Remote monitoring platform for tracking patient activity |
Detailed competitors of Endotronix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Endotronix
The website of Endotronix (endotronix.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▲ 5.8% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Endotronix (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Endotronix
Complete news archive for Endotronix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endotronix
Endotronix was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Endotronix is headquartered in East Peoria, United States. It is registered at East Peoria, Illinois, United States.
Endotronix is a funded company, having raised a total of $154.77M across 12 funding rounds to date. The company's 1st funding round was a Seed of $240K, raised on Jan 2008.
Endotronix has 104 employees.
Endotronix was founded in 2007 in East Peoria, United States, within the medical device sector focused on cardiology. Wireless and implantable pressure sensors are developed to measure cardiac function parameters. A care management solution is provided, enabling pulmonary artery pressure data to be captured via mobile devices and securely transmitted to clinical care teams for analysis and personalized patient oversight.
Endotronix's top competitors include Ekso Bionics, CoachCare and Edwards Lifesciences.
Endotronix has 12 investors. Key investors include SVB, Edwards Lifesciences, Life Sciences Partners, OSF HealthCare, and Aperture Venture Partners.
Endotronix operates through Endotronix, Inc..
Yes. Endotronix was acquired by Edwards Lifesciences in July 2024.